FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiology. Complex pharmacological support is carried out, including the use of statins, anticoagulants and antiplatelet agents, β-blockers, angiotensin-converting enzyme inhibitors. Two-stage revascularization is performed: primary percutaneous coronary intervention and delayed coronary artery stenting. At the same time, atorvostatin at a dosage of 80 mg/day is prescribed as an intensification of complex therapy from the first day of admission to the hospital until discharge, and delayed stenting of the coronary artery is carried out no earlier than 5-9 days after the primary percutaneous coronary intervention when the resorption of thrombotic masses is 50% and more from the initial ones according to the results of control coronary angiography.
EFFECT: method allows to significantly reduce the incidence of the risk of developing the "slow/no-reflow" phenomenon during coronary artery stenting in patients with acute myocardial infarction with ST-segment elevation due to massive thrombosis due to an adequate time interval during delayed coronary artery stenting and the optimal choice of statin dosage during complex therapy.
1 cl, 8 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RISK OF DEVELOPING A "NO-REFLOW" PHENOMENON IN PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION | 2018 |
|
RU2716095C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF MASSIVE CORONARY THROMBOSIS OF AN INFARCTION-RESPONSIBLE CORONARY ARTERY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2022 |
|
RU2792252C1 |
| METHOD FOR ENDOVASCULAR CORRECTION OF NO-REFLOW PHENOMENON IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION OF CULPRIT ARTERY | 2014 |
|
RU2574123C1 |
| METHOD OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH MASSIVE THROMBOSIS OF THE INFARCT-RELATED CORONARY ARTERY | 2017 |
|
RU2649572C1 |
| METHOD OF DIAGNOSING GENETIC PREDISPOSITION TO DEVELOPMENT OF PHENOMENON OF CORONARY MICROVASCULAR OBSTRUCTION DURING PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION | 2023 |
|
RU2811933C1 |
| METHOD OF DETERMINING POSTOPERATIVE MANAGEMENT OF PATIENTS WITH CORONARY HEART DISEASE BASED ON THE SELECTED CLASSES OF ANGIOGRAPHIC RESULTS OF PERCUTANEOUS CORONARY INTERVENTION | 2022 |
|
RU2802854C1 |
| METHOD OF ACUTE MYOCARDIAL INFARCTION TREATMENT | 2008 |
|
RU2365380C1 |
| METHOD OF ENDOVASCULAR TREATMENT OF THROMBOTIC OCCLUSION OF AUTOVENOUS AORTOCORONARY BYPASS GRAFTS IN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2022 |
|
RU2798161C1 |
| DIAGNOSTICS OF "no-reflow" PHENOMENON, USING TWO-DIMENSIONAL STRAIN | 2014 |
|
RU2602038C2 |
| METHOD FOR PREDICTING RISK OF INTRAOPERATIVE “NO-REFLOW” SYNDROME IN PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2017 |
|
RU2659630C1 |
